| |
| |
|
| Insider
Information: |
Kaltenbach Patrick |
| Relationship: |
President and CEO |
| City: |
Santa Clara |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
82,522 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$15,056,029 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
82,522 |
|
|
| Total
Value |
$15,056,029 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
| Percentage
Gain/Loss : |
 26.1%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Agilent Technologies Inc |
A |
Sr Vice President |
2018-03-29 |
68,547 |
|
0 |
Premium* |
|
|
Becton Dickinson & Co |
BDX |
EVP & Pres Life Scien... |
2020-06-05 |
11,612 |
2018-06-01 |
0 |
Premium* |
|
|
Mettler Toledo International Inc |
MTD |
President and CEO |
2023-11-09 |
2,363 |
2021-01-25 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MTD |
Mettler Toledo Internatio... |
President and CEO |
• – – |
2023-11-09 |
4 |
A |
$0.00 |
$0 |
D/D |
976 |
2,363 |
0 |
- |
|
| MTD |
Mettler Toledo Internatio... |
President and CEO |
• – – |
2022-03-15 |
4 |
A |
$1,319.45 |
$159,653 |
D/D |
121 |
1,387 |
0 |
- |
|
| MTD |
Mettler Toledo Internatio... |
CEO Designate |
• – – |
2021-02-17 |
4 |
B |
$1,170.00 |
$58,500 |
D/D |
50 |
1,266 |
2.74 |
% |
|
| MTD |
Mettler Toledo Internatio... |
CEO Designate |
• – – |
2021-01-25 |
4 |
A |
$0.00 |
$0 |
D/D |
1,216 |
1,216 |
0 |
- |
|
| BDX |
Becton Dickinson & Co |
EVP & Pres Life Sciences |
• – – |
2020-06-05 |
4 |
AS |
$243.20 |
$255,117 |
D/D |
(1,049) |
11,612 |
0 |
% |
|
| BDX |
Becton Dickinson & Co |
EVP & Pres Life Sciences |
• – – |
2020-06-03 |
4 |
D |
$0.00 |
$0 |
D/D |
(2,027) |
12,661 |
0 |
- |
|
| BDX |
Becton Dickinson & Co |
EVP & Pres Life Sciences |
• – – |
2020-06-02 |
4 |
AS |
$244.83 |
$54,352 |
D/D |
(222) |
14,688 |
0 |
% |
|
| BDX |
Becton Dickinson & Co |
EVP & Pres Life Sciences |
• – – |
2020-06-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(400) |
14,910 |
0 |
- |
|
| BDX |
Becton Dickinson & Co |
EVP & Pres Life Sciences |
• – – |
2019-12-12 |
4 |
OE |
$242.10 |
$1,025,536 |
D/D |
4,236 |
19,546 |
0 |
- |
|
| BDX |
Becton Dickinson & Co |
EVP & Pres Life Sciences |
• – – |
2019-12-12 |
4 |
D |
$263.23 |
$1,025,807 |
D/D |
(3,897) |
15,649 |
0 |
- |
|
| BDX |
Becton Dickinson & Co |
EVP & Pres Life Sciences |
• – – |
2019-12-12 |
4 |
S |
$263.23 |
$89,235 |
D/D |
(339) |
15,310 |
0 |
- |
|
| BDX |
Becton Dickinson & Co |
EVP & Pres Life Sciences |
• – – |
2019-12-06 |
4 |
S |
$261.51 |
$81,591 |
D/D |
(312) |
15,310 |
0 |
- |
|
| BDX |
Becton Dickinson & Co |
EVP & Pres Life Sciences |
• – – |
2019-08-09 |
4 |
S |
$253.78 |
$32,230 |
D/D |
(127) |
15,930 |
0 |
- |
|
| BDX |
Becton Dickinson & Co |
EVP & Pres Life Sciences |
• – – |
2019-08-08 |
4 |
S |
$246.53 |
$98,620 |
D/D |
(400) |
16,057 |
0 |
- |
|
| BDX |
Becton Dickinson & Co |
EVP & Pres Life Sciences |
• – – |
2019-08-08 |
4 |
D |
$246.56 |
$644,754 |
D/D |
(2,615) |
16,457 |
0 |
- |
|
| BDX |
Becton Dickinson & Co |
EVP & Pres Life Sciences |
• – – |
2019-08-08 |
4 |
OE |
$224.94 |
$644,453 |
D/D |
2,865 |
19,072 |
0 |
- |
|
| BDX |
Becton Dickinson & Co |
EVP & Pres Life Sciences |
• – – |
2019-06-10 |
4 |
OE |
$224.94 |
$644,453 |
D/D |
2,865 |
19,072 |
0 |
- |
|
| BDX |
Becton Dickinson & Co |
EVP & Pres Life Sciences |
• – – |
2019-06-10 |
4 |
D |
$241.03 |
$644,514 |
D/D |
(2,674) |
16,398 |
0 |
- |
|
| BDX |
Becton Dickinson & Co |
EVP & Pres Life Sciences |
• – – |
2019-06-10 |
4 |
S |
$241.03 |
$46,037 |
D/D |
(191) |
16,207 |
0 |
- |
|
| BDX |
Becton Dickinson & Co |
EVP & Pres Life Sciences |
• – – |
2019-06-04 |
4 |
S |
$235.00 |
$64,625 |
D/D |
(275) |
16,207 |
0 |
- |
|
| BDX |
Becton Dickinson & Co |
EVP & Pres Life Sciences |
• – – |
2019-06-03 |
4 |
A |
$0.00 |
$0 |
D/D |
12,379 |
16,482 |
0 |
- |
|
| BDX |
Becton Dickinson & Co |
EVP & Pres Life Sciences |
• – – |
2019-06-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(292) |
4,103 |
0 |
- |
|
| BDX |
Becton Dickinson & Co |
EVP & Pres Life Sciences |
• – – |
2018-11-26 |
4 |
A |
$0.00 |
$0 |
D/D |
1,862 |
4,395 |
0 |
- |
|
| BDX |
Becton Dickinson & Co |
EVP & Pres Life Sciences |
• – – |
2018-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,533 |
2,533 |
0 |
- |
|
| A |
Agilent Technologies Inc |
Sr Vice President |
• • – |
2018-03-29 |
4 |
OE |
$41.26 |
$165,040 |
D/D |
4,000 |
72,547 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
